Opera (OPRA) Earnings Analysis
Opera (OPRA) next reports earnings on 2026-08-18, consensus EPS 0.2675 USD. Last quarter (2026-02-26) it beat with EPS 0.3 USD vs 0.2375 USD est (+26.3%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 15.02.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does OPRA next report earnings?
| Next earnings date | 2026-08-18 |
|---|---|
| Consensus EPS estimate | 0.2675 USD |
| Revenue estimate | 0.18B |
OPRA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-26 | 0.3 USD | 0.2375 USD | +26.3% | Beat |
| 2025-10-29 | 0.21 USD | 0.3063 USD | -31.4% | Miss |
| 2025-08-19 | 0.18 USD | 0.205 USD | -12.2% | Miss |
| 2025-04-28 | 0.21 USD | 0.2075 USD | +1.2% | Beat |
| 2025-02-27 | 0.32 USD | 0.23 USD | +39.1% | Beat |
| 2024-08-22 | 0.22 USD | 0.17 USD | +29.4% | Beat |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
OPRA valuation and analyst view
| Trailing P/E | 15.02 |
|---|---|
| Trailing EPS | 1.268 USD |
| Price / book | 1.76 |
| Dividend yield | 4.16% |
| Market cap | 1.70B |
| Analyst consensus | Buy (7 buy / 0 hold / 0 sell) |
| Avg price target | 21.5 USD |
Related research pages
Frequently asked questions
When is Opera (OPRA)'s next earnings date?
Opera is next scheduled to report on 2026-08-18, with a consensus EPS estimate of 0.2675 USD and revenue estimate of 0.18B.
Did OPRA beat earnings last quarter?
In its 2026-02-26 report, OPRA posted EPS of 0.3 USD versus a 0.2375 USD estimate — a beat of 26.3%.
What is OPRA's earnings track record?
Over the last 6 reported quarters with consensus data, OPRA beat estimates 4 times (67%).
What is OPRA's current P/E ratio and EPS?
OPRA trades at a trailing P/E of 15.02 on trailing EPS of 1.2679264327162199 USD.
What do analysts rate OPRA?
Analyst consensus is "Buy" across 7 ratings (0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 21.5 USD.